Benefits of RPA in the pharmaceutical industry

  • Reduced time to market. Software robots can complete repetitive, tedious tasks promptly and with quasi perfect accuracy. As a consequence, the collection of real-time information can proceed at a much faster pace, and clinical trials are facilitated. This means that the bots allow pharma companies to come up with new medicines in much shorter time, which improves productivity and performance.
  • Facilitate management of regulatory compliance requirements. Because it cuts down the possibility of human error, RPA strengthens compliance with stringent standards and increasingly complex regulations.
  • ROI maximisation. Automation of routine tasks helps pharmaceutical companies reduce their production and compliance costs, which results in higher return on investment.
  • Increased agility. RPA in the realm of pharmaceutical companies may take advantage of the lessons learned from other industry sectors, which have embarked on the automation journey earlier, e.g., finance, healthcare, insurance, etc. Starting with realistic expectations, providing employees with (re)skilling opportunities, or supporting developers’ communication with users are among the most useful approaches to ensure automation buy-in within the company.

Use cases of RPA in the pharmaceutical industry

1. Foster individualized marketing

2. Facilitate clinical development



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store


CiGen, one of the first dedicated (#RPA) #Robotic #Process #Automation companies, providing Intelligent Automation solutions and services, using @uipath